News related to Buminate 25% (Albumin) and/or conditions it is approved for
Microalbuminuria as a Risk Predictor in Diabetes
Source: Medscape Diabetes & Endocrinology Headlines [2014.04.08]
Do you screen your patients with cardiovascular disease for microalbuminuria? This research suggests that you should.
Atrasentan May Work in Diabetic Kidney Disease (CME/CE)
Source: MedPageToday.com - medical news plus CME for physicians [2014.04.11]
(MedPage Today) -- Adding the endothelin receptor antagonist atrasentan to renin-angiotensin blockade reduced albuminuria without major side effects in patients with diabetic nephropathy, researchers found.
Diabetic Nephropathy - Early intervention is the key
Source: The Doctors Lounge - Nephrology
Dr. Riham explains how annual screening for microalbuminuria in diabetic patients will allow early identification of nephropathy.